Health Signal — Statement on the planned hepatitis B birth dose vaccine tria — OpenWatch

Real-time global intelligence

© 2026 OpenWatch. All rights reserved.

For informational and entertainment purposes only. Not investment advice.

Platform

Brief
Signals
Countries
Companies
Industries
Themes
Scenarios
Rankings

Tools

Globe
Analytics
Crises
Clusters
Supply Chain
Alliances
Screener
Watchlist
Portfolio

Developer

API Reference
Developer Keys
Webhooks
Status

Sources

View all sources →

1,000+ tracked sources

Signals updated every 15 minutes

Not investment advice. OpenWatch is provided for informational and entertainment purposes only. While we strive for accuracy, precision, and source attribution in all intelligence assessments, geopolitical analysis involves inherent uncertainty and our conclusions may be incomplete, delayed, or incorrect. Nothing on this platform constitutes financial, investment, legal, or professional advice of any kind. Forward-looking scenarios and probability estimates are analytical hypotheses — not independently validated forecasts. Any actions taken based on information found here are solely your responsibility. Always consult a qualified financial advisor before making investment decisions. Past signal patterns do not guarantee future outcomes.

Methodology
Privacy Policy
Terms of Use

openwatch.io

v·cd95e35

← Back to search

HealthupdateFebruary 14, 2026

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

This is an ingested summary. Full reporting is available at the primary source below.

Severity: 5.0/10Source: WHO Disease Outbreaks

Read full report ↗Related signals →

Health Signal — Statement on the planned hepatitis B birth dose vaccine tria — OpenWatch